8-23114722-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_003841.5(TNFRSF10C):c.232G>A(p.Ala78Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000843 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_003841.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFRSF10C | NM_003841.5 | c.232G>A | p.Ala78Thr | missense_variant | 3/5 | ENST00000356864.4 | NP_003832.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFRSF10C | ENST00000356864.4 | c.232G>A | p.Ala78Thr | missense_variant | 3/5 | 1 | NM_003841.5 | ENSP00000349324.4 | ||
ENSG00000284956 | ENST00000520607 | c.-10G>A | 5_prime_UTR_variant | 5/6 | 4 | ENSP00000493787.1 | ||||
TNFRSF10C | ENST00000517558.1 | n.126G>A | non_coding_transcript_exon_variant | 2/4 | 2 | ENSP00000428235.1 | ||||
TNFRSF10C | ENST00000518135.1 | n.216G>A | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251490Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135918
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461794Hom.: 0 Cov.: 30 AF XY: 0.0000660 AC XY: 48AN XY: 727192
GnomAD4 genome AF: 0.000302 AC: 46AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.000458 AC XY: 34AN XY: 74284
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at